SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Caliper Technologies - CALP
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (59)12/18/2000 10:20:50 PM
From: keokalani'nui  Read Replies (2) of 114
 
Looks on its face to be a just result given there has already been a finding of trade secret misappropriation (by patent counsel, oooh....that was bad...probably no indemnification for that one). Frankly if I had known Calp sought a constructive trust as its remedy I might have been less optimistic, and I'm glad the court had, and exercised, its equitable powers to do the right thing.

The real news, buried in aclara's PR, however makes me think the only value of '015 to aclara was to enjoin calp's use, which of course means aclara lost big time:

>>As indicated previously, ACLARA plans to appeal the judgment in this case, including the order of injunctive relief. <<

Next, calp proceeds to assert its IP against aclara, unless the rulings on T-intersections allowed the lawyers to work out an amicable arrangement in the meantime ha ha ha.

Then maybe someday, either company can show us that microfuidics can do a better job making money for investors than the manufacturers of chip arrays.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News